Lansoprazol Generis

Lansoprazole, the active ingredient in Lansoprazol Generis, is a proton pump inhibitor presented as an oral tablet for systemic use. By selectively inhibiting the gastric proton pump, it lowers stomach acidity and is indicated for the treatment and maintenance of acid‑related gastrointestinal conditions in adult patients.

GNH USA supplies Lansoprazol Generis as a licensed, GDP‑compliant international pharmaceutical supplier, providing consistent quality to hospitals, pharmacies and clinics across global markets, ensuring regulatory compliance and reliable delivery.

Lansoprazole is indicated for several acid‑related gastrointestinal conditions.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. - Erosive esophagitis: promotes healing of inflamed esophageal tissue caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations by suppressing gastric acid.

Lansoprazole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of stomach upset. - Abdominal pain: mild discomfort in the upper abdomen.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Hypomagnesemia: low magnesium levels, may cause muscle cramps or arrhythmia. - Interstitial nephritis: kidney inflammation requiring medical attention. - Fracture risk: reduced bone density with long‑term use.

When prescribing lansoprazole, clinicians should consider several safety aspects.

- Assess renal function: dose may need adjustment in severe impairment. - Monitor electrolytes: prolonged use can lower magnesium and potassium levels. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use caution in pregnancy: safety data limited, weigh benefits versus risks. - Store at ambient temperature: keep below 25 °C, protect from moisture in the original packaging.

Lansoprazole can affect the pharmacokinetics of other medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect; avoid co‑administration. - Atazanavir: decreased antiviral absorption; avoid. - Methotrexate (high dose): increased toxicity; avoid.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR. - Digoxin: increased serum levels; monitor for toxicity. - Diazepam: increased sedation; observe patient response.